Electric eye therapy: can a home device slow blindness?

NCT ID NCT07531927

Recruiting now Disease control Sponsor: Okuvision GmbH Source: ClinicalTrials.gov ↗

First seen Jun 27, 2026 · Last updated Jul 29, 2026 · Updated 2 times

Summary

This study tests if a device that delivers mild electrical pulses to the eye (transcorneal electrical stimulation) can safely slow the progression of geographic atrophy, an advanced form of age-related macular degeneration that causes vision loss. About 70 people aged 60 and older will use the device at home for 30 minutes once a week for a year. The study compares two different types of electrical stimulation against a sham (placebo) treatment to see which works best.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for GEOGRAPHIC ATROPHY SECONDARY TO AGE-RELATED MACULAR DEGENERATION are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

age-related macular degeneration Geographic Atrophy

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

GEOGRAPHIC ATROPHY SECONDARY TO AGE-RELATED MACULAR DEGENERATION

Contacts and locations

Show contact details

Study contacts

Contact

Email: •••••@•••••

Locations

Centre for Ophthalmology, University Hospital Tuebingen
RECRUITING

Tübingen, 72076, Germany
Department of Ophthalmology, Klinikum Stuttgart
RECRUITING

Stuttgart, 70174, Germany
Department of Ophthalmology, Ludwig-Maximilians-University Munich
RECRUITING

München, 80336, Germany
Department of Ophthalmology, University Hospital Ulm
NOT_YET_RECRUITING

Ulm, 89075, Germany
Department of Ophthalmology, University Medical Center Hamburg-Eppendorf
RECRUITING

Hamburg, 20246, Germany

More trials for these conditions

Other studies related to the condition(s) this trial covers.